Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Valeant Pharmaceuticals Intl (VRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
International Ophthalmology and Optometry Devices Market Booming With New Growth Opportunities

MarketNewsUpdates.com News Commentary

VRX.TO : 30.80 (-3.33%)
EYC.VN : 0.245 (+6.52%)
EYEG : 0.60 (-1.64%)
EYCCF : 0.1900 (+1.66%)
STAA : 33.90 (unch)
AGN : 171.79 (-0.92%)
VRX : 23.40 (-3.43%)
Implied Volatility Surging for Valeant Pharmaceuticals (VRX) Stock Options

Investors in Valeant Pharmaceuticals (VRX) need to pay close attention to the stock based on moves in the options market lately.

VRX : 23.40 (-3.43%)
Drug Pricing in Focus Again as Trump Tweet Slams Pfizer

In a tweet, Trump says Pfizer and other U.S. drugmakers should be "ashamed" that they have raised drug prices for "no reason".

MYL : 35.53 (-0.31%)
MRK : 62.52 (+0.02%)
VRX : 23.40 (-3.43%)
PFE : 37.33 (-0.08%)
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%

PDUFA Date Set for February 25, 2019

VRX.TO : 30.80 (-3.33%)
VRX : 23.40 (-3.43%)
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%

PDUFA Date Set for February 25, 2019

VRX.TO : 30.80 (-3.33%)
VRX : 23.40 (-3.43%)
Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA(TM) (lofexidine)

US WorldMeds, LLC and Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention...

VRX.TO : 30.80 (-3.33%)
VRX : 23.40 (-3.43%)
Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA™ (lofexidine)

LOUISVILLE, Ky. and BRIDGEWATER, N.J. , June 26, 2018 /PRNewswire/ -- US WorldMeds, LLC and Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC ("Salix"), one of the...

VRX.TO : 30.80 (-3.33%)
VRX : 23.40 (-3.43%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valeant Pharmaceuticals International, Inc. - VRX

NEW YORK, NY / ACCESSWIRE / June 23, 2018 / Pomerantz LLP is investigating claims on behalf of investors of Valeant Pharmaceuticals International, Inc. ("Valeant" or the "Company") (NYSE: VRX). Such investors...

VRX.TO : 30.80 (-3.33%)
VRX : 23.40 (-3.43%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valeant Pharmaceuticals International, Inc. - VRX

Pomerantz LLP is investigating claims on behalf of investors of Valeant Pharmaceuticals International, Inc. ("Valeant" or the "Company") . Such investors are advised to contact Robert S. Willoughby...

VRX.TO : 30.80 (-3.33%)
VRX : 23.40 (-3.43%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valeant Pharmaceuticals International, Inc. - VRX

NEW YORK , June 19, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Valeant Pharmaceuticals International, Inc. ("Valeant" or the "Company") (NYSE: VRX).  ...

VRX : 23.40 (-3.43%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valeant Pharmaceuticals International, Inc. - VRX

Pomerantz LLP is investigating claims on behalf of investors of Valeant Pharmaceuticals International, Inc. ("Valeant" or the "Company") (NYSE: VRX). Such investors are advised to contact Robert S....

VRX.TO : 30.80 (-3.33%)
VRX : 23.40 (-3.43%)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Valeant Pharmaceuticals International, Inc. (VRX)

NEW YORK , June 19, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Valeant Pharmaceuticals International,...

VRX : 23.40 (-3.43%)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Valeant Pharmaceuticals International, Inc. (VRX)

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Valeant Pharmaceuticals International, Inc. ("Valeant" or the "Company") (NYSE: VRX)....

VRX.TO : 30.80 (-3.33%)
VRX : 23.40 (-3.43%)
Valeant Down as FDA Refuses to Approve Duobrii For Psoriasis

Valeant (VRX) suffers a setback as the FDA issues a CRL for its plaque psoriasis lotion, Duobrii.

AGLE : 9.20 (-1.18%)
AZN : 37.17 (+0.38%)
ILMN : 311.15 (+0.66%)
VRX : 23.40 (-3.43%)
Company News For Jun 19, 2018

Companies in the news are: JD,GOOGL,VRX,SLDB,TSLA

GOOGL : 1,197.88 (-0.10%)
SLDB : 43.11 (-2.27%)
TSLA : 313.58 (-2.08%)
JD : 35.51 (-3.71%)
VRX : 23.40 (-3.43%)
FDA Issues Complete Response Letter For DUOBRII(TM) (Halobetasol Propionate and Tazarotene) Lotion

Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX), today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration...

VRX.TO : 30.80 (-3.33%)
VRX : 23.40 (-3.43%)
FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion

LAVAL, Quebec , June 18, 2018 /PRNewswire/ -- Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX), today announced that it has received a Complete Response...

VRX.TO : 30.80 (-3.33%)
VRX : 23.40 (-3.43%)
Zacks Value Investor Highlights: Gilead Sciences, Biogen, Celgene, Lannett and Valeant

Zacks Value Investor Highlights: Gilead Sciences, Biogen, Celgene, Lannett and Valeant

CELG : 85.10 (-0.28%)
LCI : 12.35 (-3.52%)
GILD : 77.37 (+0.42%)
VRX : 23.40 (-3.43%)
BIIB : 358.71 (+0.17%)
Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops

Now Available at Major U.S. Retailers

VRX.TO : 30.80 (-3.33%)
VRX : 23.40 (-3.43%)
Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops

Now Available at Major U.S. Retailers

VRX.TO : 30.80 (-3.33%)
VRX : 23.40 (-3.43%)

Van Meerten Stock Picks

5 Terrific Mid Caps
In this roller coaster market I wanted to find Mid Cap stocks that had consistent price appreciation over the last 6 month period.
EHC -0.38 , FTNT +0.53 , CAKE -0.45 , PLT -0.28 , AEO -0.65
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Agricharts Market Commentary

Today's Commentary

Corn futures closed the week with most contracts 3 to 4 cents higher on Friday. Nearby September was up 4.1% since last Friday, with higher closes every day this week. Solid exports and drier weather fueled some bottom picking and short covering acti...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar